These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3566613)

  • 21. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
    Weiss JN
    Am J Ophthalmol; 1998 Jul; 126(1):142-4. PubMed ID: 9683166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Wegner CD; Cox BF
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
    J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of thrombolysis in peripheral arterial occlusion.
    McNamara TO
    Am J Med; 1987 Aug; 83(2A):6-10. PubMed ID: 3631116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined central retinal arterial and venous obstruction: emergency ophthalmic arterial fibrinolysis.
    Vallée JN; Paques M; Aymard A; Massin P; Santiago PY; Adeleine P; Gaudric A; Merland JJ
    Radiology; 2002 May; 223(2):351-9. PubMed ID: 11997537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
    Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
    J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.
    Denardo SJ; Morris NB; Rocha-Singh KJ; Curtis GP; Rubenson DS; Teirstein PS
    Am J Cardiol; 1995 Oct; 76(11):776-80. PubMed ID: 7572653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Simultaneous urokinase perfusion in renal artery and vein in a case of renal vein thrombosis].
    Stella N; Rolli A; Catalano A; Udini M
    Minerva Cardioangiol; 2001 Aug; 49(4):273-8. PubMed ID: 11426198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.
    Glacet-Bernard A; Kuhn D; Vine AK; Oubraham H; Coscas G; Soubrane G
    Br J Ophthalmol; 2000 Jun; 84(6):609-13. PubMed ID: 10837386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits.
    Wu J; Zhou X; Hu Y; Zhang T; Ma Z; Li X; Su L; Wang J; Lin S
    Retina; 2010 Jun; 30(6):966-70. PubMed ID: 20094009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of tissue plasminogen activator and urokinase in a canine model of prosthetic graft thrombosis.
    Curl GR; Jakubowski JA; Nabseth DC; Bush HL
    Arch Surg; 1986 Jul; 121(7):782-8. PubMed ID: 3087327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
    Huang DX; Song A; Yang X; Wang S
    Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The modality of huoxue-huayu in treatment of retinal vein occlusion.
    Deng Y; Wang M; Duan J
    Yan Ke Xue Bao; 1995 Mar; 11(1):57-60. PubMed ID: 8575610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus.
    Pang D; Sclabassi RJ; Horton JA
    Neurosurgery; 1986 Oct; 19(4):553-72. PubMed ID: 3491340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
    Sakuragawa N; Takahashi K
    Rinsho Ketsueki; 1977 Jun; 18(6):726-31. PubMed ID: 916203
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
    Bagnall HA; Gomperts E; Atkinson JB
    Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.